Mirae Asset Global Investments
SMMT icon

Mirae Asset Global Investments’s Summit Therapeutics SMMT Stock Holding History

Mirae Asset Global Investments’s Portfolio SMMT Stock Details SMMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$523K Sell
35,876
-6,507
-15% -$115K ﹤0.01% 971
2026
Q1 		$804K Buy
42,383
+4,392
+12% +$71K ﹤0.01% 870
2025
Q4 		$664K Buy
37,991
+7,403
+24% +$139K ﹤0.01% 957
2025
Q3 		$632K Buy
30,588
+40
+0.1% +$970 ﹤0.01% 945
2025
Q2 		$650K Buy
30,548
+4,030
+15% +$91.9K ﹤0.01% 905
2025
Q1 		$539K Buy
26,518
+135
+0.5% +$2.71K ﹤0.01% 913
2024
Q4 		$480K Buy
26,383
+178
+0.7% +$3.45K ﹤0.01% 952
2024
Q3 		$547K Buy
26,205
+5,247
+25% +$73.4K ﹤0.01% 946
2024
Q2 		$165K Sell
20,958
-19,518
-48% -$105K ﹤0.01% 1077
2024
Q1 		$168K Buy
40,476
+22,977
+131% +$91.3K ﹤0.01% 2300
2023
Q4 		$45.7K Buy
17,499
+1,108
+7% +$2.28K ﹤0.01% 2517
2023
Q3 		$30.7K Buy
16,391
+617
+4% +$1.18K ﹤0.01% 2560
2023
Q2 		$39.6K Sell
15,774
-1,436
-8% -$2.62K ﹤0.01% 2597
2023
Q1 		$30.1K Buy
+17,210
New +$46.9K ﹤0.01% 2522

Other funds holding SMMT

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
ACL
APEIRON Capital Ltd Hong Kong $156M AUM 183.17% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
HWM
Hohimer Wealth Management Seattle, Washington $1B AUM 33.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Mirae Asset Global Investments's SMMT Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Summit Therapeutics (SMMT) stake by 15% in Q2 2026, selling an estimated $115K and leaving 35,876 shares worth $523K. The position accounts for ﹤0.01% of the portfolio, ranked #971.

Mirae Asset Global Investments first reported a position in SMMT in Q1 2023 and has held it in 14 quarters since. The position peaked at $804K in Q1 2026. 86 funds tracked by Wall St. Rank hold SMMT as of Q2 2026.

  • Mirae Asset Global Investments held 35,876 shares of Summit Therapeutics worth $523K as of Q2 2026.
  • Mirae Asset Global Investments sold 6,507 Summit Therapeutics shares in Q2 2026, an estimated $115K.
  • Summit Therapeutics made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #971 holding.
  • Mirae Asset Global Investments first reported a position in Summit Therapeutics in Q1 2023 and has held it in 14 quarters since.
  • Mirae Asset Global Investments's Summit Therapeutics position peaked at $804K in Q1 2026.
  • 86 funds tracked by Wall St. Rank held Summit Therapeutics as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.